Scientific program
Angiography Intensive CourseFriday, 27th March |
|
|---|---|
15:30 19:30 |
Angiography Intensive Course: Chairmen and moderation: Albert J. Augustin (Karlsruhe, Germany) Norbert Bornfeld (Essen, Germany) Bernd Kirchhof (Cologne, Germany) Case presentations by members of the faculty 1. Introduction/ Phenomena / Differential Diagnosis 2. Retinal Vascular Diseases and AMD 3. Tumors, inflammatory and vascular occlusive diseases 4. Case presentations |
| 19:30 | Welcome dinner Foyer Konzerthaus Karlsruhe / Foyer Concert Hall Karlsruhe |
SymposiumSaturday, 28th March 2009 |
|
| 08:30 08:45 |
Opening Ceremony Professor Dr. Horst Hippler President – University of Karlsruhe, Germany |
| 08:45 09:40 |
1st Scientific Session:Microincision SurgeryQuestion/Topic: A real step forward or "safety first"Chairmen and moderation: Stanislao Rizzo (Pisa, Italy) Gisbert Richard (Hamburg, Germany) |
| 08:45 1 | Stanislao Rizzo (Pisa, Italy) New 25 and 23 Gauge Technologies - How can they improve our results? |
| 09:00 2 | Periklis Brazitikos (Thessaloniki, Greece) Instrumentation in the age of Microincision vitrectomy The mandatory instrument set |
| 09:15 3 | Donald J. D'Amico (New York, USA) Tipps and Tricks for Microincision Surgery |
| 09:30 4 | Stanislao Rizzo, Donald J. D'Amico (Pisa, Italy; New York, USA) Complications of Sutureless Vitrectomy: Any news from the Microsurgical Safety Task Force? |
| 09:40 10:50 |
2nd Scientific Session:What is new in vitreoretinal surgery?Chairmen and moderation: Donald J. D'Amico (New York, USA) Gisbert Richard (Hamburg, Germany) |
| 09:40 5 | Baruch D. Kupperman (Irvine, USA) Macular hole surgery Recommendations 2009 – New holes – Re-opened holes Should we operate lamellar holes? |
| 09:50 6 | Tom S. Chang (Pasadena, USA) Choroidal buckles: A novel method of Macular hole repair |
| 09:55 7 | Bernd Kirchhof (Cologne, Germany) Long term results of free transplants in geographic atrophy (AMD) |
| 10:10 8 | Tom S. Chang (Pasadena, USA) Suprachoroidal drug delivery via catheter A Medico-Surgical Approach to wet AMD |
| 10:20 9 | Manfred R. Tetz (Berlin, Germany) Interventional drug application A report from outer space |
| 10:30 10 | Stanislao Rizzo, A.J. Augustin (Pisa, Italy; Karlsruhe, Germany) PVR - A complication still frightening the surgeon? News from medical retina? |
| 10:40 11 | Gisbert Richard (Hamburg, Germany) Artificial Vision - A Status Report |
| 10:50 11:10 |
Coffee break in the industrial exhibition area |
| 11:10 12:50 |
3st Scientific Session:Diabetic RetinopathyNew drugs/new laser technologiesChairmen and moderation: Neil M. Bressler (Baltimore, USA) Antonia M. Joussen (Düsseldorf, Germany) |
| 11:10 12 | Norbert Bornfeld (Essen, Germany) Anti-VEGF before / during / after surgery Rationale and disease stages |
| 11:20 13 | Neil M. Bressler (Baltimore, USA) Advanced Laser Concepts in Diabetic Retinopathy |
| 11:35 14 | Susan B. Bressler (Baltimore, USA) Nutrition Supplementation for AMD and Diabetic Retinopathy |
| 11:50 15 | Baruch D. Kupperman (Irvine, USA) Diabetic Retinopathy - Medical Management in 2009 (Anti-VEGF / Steroids) |
| 12:05 16 | Susan B. Bressler (Baltimore, USA) Laser response in diabetic macular edema (DME) |
| 12:20 17 | Neil M. Bressler (Baltimore, USA) Vitrectomy for diabetic macular edema Is early Vitrectomy still an approach to be considered? |
| 12:35 18 | Francesco Bandello (Udine, Italy) DME: A comprehensive treatment algorithm |
| 12:50 13:15 |
4th Scientific Session:Tumors - An updateChairmen and moderation: Norbert Bornfeld (Essen, Germany) Thorsten Böker (Dortmund, Germany) |
| 12:50 19 | Thorsten Böker (Dortmund, Germany) Imaging of ocular tumors Is there a #1 technique? Do we need a combination? |
| 13:00 20 | Norbert Bornfeld (Essen, Germany) Diagnostics and Treatment of ocular melanoma in 2009 |
| 13:15 14:15 |
Lunch and coffee break in the industrial exhibition area Afternoon Session: Imaging, AMD and medical Retina |
| 14:15 15:30 |
5th Scientific Session:Imaging and AMD 1Chairmen and moderation: Ursula Schmidt-Erfurth (Vienna, Austria) Susan B. Bressler (Baltimore, USA) |
| 14:15 21 | Thorsten Böker (Dortmund, Germany) Combined use of OCT / angiography / other technologies Is this a major step forward in the diagnosis of macular diseases? |
| 14:30 22 | Ursula Schmidt-Erfurth (Vienna, Austria) New OCT-Technologies Spectral Domain OCT: Substance or Hype? |
| 14:45 23 | Anthony P. Adamis (New York, USA) The role of inflammation in the pathogenesis of AMD Prevention of Dry and Wet AMD |
| 15:00 24 | Ursula Schmidt-Erfurth (Vienna, Austria) Wet AMD: A comprehensive treatment algorithm for all lesion types |
| 15:15 25 | William F. Mieler (Chicago, USA) Endophthalmitis in the age of intravitreal injections How to prevent - how to treat? Do we have to change the concept? |
| 15:30 18:00 |
Coffee / Snacks in the meeting room |
| 15:30 16:40 |
6th Scientific Session:Old drugs, new drugs, combination strategiesChairmen and moderation: Gisele Soubrane (Cr&eacue;teil, France) Susan B. Bressler (Baltimore, USA) |
| 15:30 26 | Periklis Brazitikos (Thessaloniki, Greece) Pegaptanib for AMD and DME |
| 15:40 27 | Francesco Bandello (Udine, Italy) Ranibizumab and Bevacizumab for AMD and DME |
| 15:50 28 | Antonia Joussen (Düsseldorf, Germany) Combination strategies for wet AMD |
| 16:00 29 | Bernd Kirchhof (Cologne, Germany) At the end of intravitreal Anti-VEGF results after termination of injection |
| 16:10 30 | William F. Mieler (Chicago, USA) New Treatment Strategies for dry and wet AMD What is new and promising in Phase 2 and 3 VEGF-Trap // Sirolimus // Anti-Inflammatory drugs // Fenretinide and others |
| 16:25 31 | Paolo Lanzetta (Udine, Italy) Dexamethasone devices and other steroids for the treatment of retinal diseases. Are they changing our treatment approaches? |
| 16:40 18:00 |
6th Scientific Session:AMD 2Dry AMD, in / off label, AMD and angiology, light toxicityChairmen and moderation: Antonia M. Joussen (Düsseldorf, Germany) Susan B. Bressler (Baltimore, USA) |
| 16:40 | Gisèle Soubrane, T.S. Chang (Créteil, France; Pasadena, USA) Interactive Presentation Lucentis in portions or Avastin - Is there a difference? What is the difference between Avastin and Lucentis? |
| 16:50 | Brit Lehmann (Karlsruhe, Germany) Prostavasin - News from the AIMS trial |
| 17:00 | Anthony P. Adamis (New York, USA) Is there a treatment for dry AMD? |
| 17:15 | Curt Diehm (Karlsbad-Langensteinbach, Germany) AMD and vascular diseases. Is there a common pathogenesis? |
| 17:30 | Baruch D. Kupperman (Irvine, USA) Is topical therapy the future of AMD-treatment? |
| 17:45 | Thomas Neuhann (Munich, Germany) Blue filtering lenses. Marketing or scientific rationale? |
| 18:00 | Discussion // Closing Remarks |